214 related articles for article (PubMed ID: 17956317)
1. Synaptic memory mechanisms: Alzheimer's disease amyloid beta-peptide-induced dysfunction.
Rowan MJ; Klyubin I; Wang Q; Hu NW; Anwyl R
Biochem Soc Trans; 2007 Nov; 35(Pt 5):1219-23. PubMed ID: 17956317
[TBL] [Abstract][Full Text] [Related]
2. Synaptic plasticity disruption by amyloid beta protein: modulation by potential Alzheimer's disease modifying therapies.
Rowan MJ; Klyubin I; Wang Q; Anwyl R
Biochem Soc Trans; 2005 Aug; 33(Pt 4):563-7. PubMed ID: 16042545
[TBL] [Abstract][Full Text] [Related]
3. Synaptic plasticity in animal models of early Alzheimer's disease.
Rowan MJ; Klyubin I; Cullen WK; Anwyl R
Philos Trans R Soc Lond B Biol Sci; 2003 Apr; 358(1432):821-8. PubMed ID: 12740129
[TBL] [Abstract][Full Text] [Related]
4. Soluble amyloid-beta peptides potently disrupt hippocampal synaptic plasticity in the absence of cerebrovascular dysfunction in vivo.
Hu NW; Smith IM; Walsh DM; Rowan MJ
Brain; 2008 Sep; 131(Pt 9):2414-24. PubMed ID: 18678563
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of the inhibitory effects of amyloid beta-protein on synaptic plasticity.
Rowan MJ; Klyubin I; Wang Q; Anwyl R
Exp Gerontol; 2004; 39(11-12):1661-7. PubMed ID: 15582282
[TBL] [Abstract][Full Text] [Related]
6. Arginine vasopressin prevents amyloid beta protein-induced impairment of long-term potentiation in rat hippocampus in vivo.
Jing W; Guo F; Cheng L; Zhang JF; Qi JS
Neurosci Lett; 2009 Feb; 450(3):306-10. PubMed ID: 19059464
[TBL] [Abstract][Full Text] [Related]
7. Alpha v integrins mediate beta-amyloid induced inhibition of long-term potentiation.
Wang Q; Klyubin I; Wright S; Griswold-Prenner I; Rowan MJ; Anwyl R
Neurobiol Aging; 2008 Oct; 29(10):1485-93. PubMed ID: 17442458
[TBL] [Abstract][Full Text] [Related]
8. Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivo.
Klyubin I; Walsh DM; Lemere CA; Cullen WK; Shankar GM; Betts V; Spooner ET; Jiang L; Anwyl R; Selkoe DJ; Rowan MJ
Nat Med; 2005 May; 11(5):556-61. PubMed ID: 15834427
[TBL] [Abstract][Full Text] [Related]
9. Orally available compound prevents deficits in memory caused by the Alzheimer amyloid-beta oligomers.
Townsend M; Cleary JP; Mehta T; Hofmeister J; Lesne S; O'Hare E; Walsh DM; Selkoe DJ
Ann Neurol; 2006 Dec; 60(6):668-76. PubMed ID: 17192927
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer amyloid beta-peptide A-beta25-35 blocks adenylate cyclase-mediated forms of hippocampal long-term potentiation.
Bisel BE; Henkins KM; Parfitt KD
Ann N Y Acad Sci; 2007 Feb; 1097():58-63. PubMed ID: 17413011
[TBL] [Abstract][Full Text] [Related]
11. The role of cell-derived oligomers of Abeta in Alzheimer's disease and avenues for therapeutic intervention.
Walsh DM; Klyubin I; Shankar GM; Townsend M; Fadeeva JV; Betts V; Podlisny MB; Cleary JP; Ashe KH; Rowan MJ; Selkoe DJ
Biochem Soc Trans; 2005 Nov; 33(Pt 5):1087-90. PubMed ID: 16246051
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of S14G-humanin against beta-amyloid induced LTP inhibition in mouse hippocampal slices.
Zhang W; Miao J; Hao J; Li Z; Xu J; Liu R; Cao F; Wang R; Chen J; Li Z
Peptides; 2009 Jun; 30(6):1197-202. PubMed ID: 19463756
[TBL] [Abstract][Full Text] [Related]
13. Prevention of amyloid beta-induced memory impairment by fluvastatin, associated with the decrease in amyloid beta accumulation and oxidative stress in amyloid beta injection mouse model.
Kurinami H; Sato N; Shinohara M; Takeuchi D; Takeda S; Shimamura M; Ogihara T; Morishita R
Int J Mol Med; 2008 May; 21(5):531-7. PubMed ID: 18425343
[TBL] [Abstract][Full Text] [Related]
14. Chronic psychosocial stress exacerbates impairment of cognition and long-term potentiation in beta-amyloid rat model of Alzheimer's disease.
Srivareerat M; Tran TT; Alzoubi KH; Alkadhi KA
Biol Psychiatry; 2009 Jun; 65(11):918-26. PubMed ID: 18849021
[TBL] [Abstract][Full Text] [Related]
15. LPYFDa neutralizes amyloid-beta-induced memory impairment and toxicity.
Granic I; Masman MF; Kees Mulder C; Nijholt IM; Naude PJ; de Haan A; Borbély E; Penke B; Luiten PG; Eisel UL
J Alzheimers Dis; 2010; 19(3):991-1005. PubMed ID: 20157254
[TBL] [Abstract][Full Text] [Related]
16. The effects of IL-1 receptor antagonist on beta amyloid mediated depression of LTP in the rat CA1 in vivo.
Schmid AW; Lynch MA; Herron CE
Hippocampus; 2009 Jul; 19(7):670-6. PubMed ID: 19115392
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase C mediates amyloid beta-protein fragment 31-35-induced suppression of hippocampal late-phase long-term potentiation in vivo.
Zhang JF; Qi JS; Qiao JT
Neurobiol Learn Mem; 2009 Mar; 91(3):226-34. PubMed ID: 19061963
[TBL] [Abstract][Full Text] [Related]
18. Insulin rescues amyloid beta-induced impairment of hippocampal long-term potentiation.
Lee CC; Kuo YM; Huang CC; Hsu KS
Neurobiol Aging; 2009 Mar; 30(3):377-87. PubMed ID: 17692997
[TBL] [Abstract][Full Text] [Related]
19. Beta-amyloid oligomers affect the structure and function of the postsynaptic region: role of the Wnt signaling pathway.
Dinamarca MC; Colombres M; Cerpa W; Bonansco C; Inestrosa NC
Neurodegener Dis; 2008; 5(3-4):149-52. PubMed ID: 18322375
[TBL] [Abstract][Full Text] [Related]
20. [Effects of amyloid β-protein on hippocampal long-term potentiation].
Zhang JF; Yang D; Qi JS
Sheng Li Xue Bao; 2010 Dec; 62(6):479-88. PubMed ID: 21170492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
